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INTRODUCTION
Bovine respiratory disease complex (BRDC) is 
the largest economic problem facing the U.S. cattle 
industry. Annual economic losses due to death, de-
creased feed efficiency, and treatment costs associ-
ated with BRDC are estimated at US$800 to $900 
million (Chirase et al., 2001) and BRDC accounts for 
approximately 75% of feedlot morbidity and from 50 
to 80% of mortality (Edwards, 1996; Chirase et al., 
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ABSTRACT: Bovine respiratory disease complex 
(BRDC) is the leading cause of morbidity and mor-
tality in feedlot cattle. Significant inflammation and 
lesions are often observed in lungs of infected cattle. 
During acute inflammatory responses, histones con-
tribute to mortality in rodents and humans and serum 
proteins can protect against histone-induced cytotoxic-
ity. We hypothesized that cattle experiencing chronic 
or fatal cases of BRDC have reduced ability to protect 
against cytotoxic effects of histones. Serum samples 
were collected from 66 bull calves at the time of nor-
mal feedlot processing procedures. Animals were 
retrospectively assigned to groups consisting of calves 
never treated for BRDC (control [CONT]; n = 10), 
calves treated with antimicrobials once for BRDC (1T; 
n = 16), calves treated twice for BRDC (2T; n = 13), 
calves treated 3 times for BRDC (3T; n = 14), or calves 
treated 4 times for BRDC (4T; n = 13). Samples were 
also collected each time animals received antimicro-
bial treatment; animals within a group were further 
sorted by calves that recovered and calves that died to 
test histone cytotoxicity. Bovine kidney cells were cul-
tured in duplicate in 96-well plates and exposed to 0 
or 50 μg/mL of total histones for 18 h with 1% serum 
from each animal. Cell viability was assessed by the 
addition of resazurin for 6 h followed by fluorescent 
quantification. Fluorescent values from serum alone 
were subtracted from values obtained for histone treat-
ment for each animal. Serum from CONT, 1T, and 2T 
at initial processing all exhibited a similar (P > 0.10) 
response to histone treatment with fluorescent values 
of –312 ± 557, –1,059 ± 441, and –975 ± 489, respec-
tively. However, 3T and 4T demonstrated an impaired 
capacity (P < 0.05) to protect against histones (–2,778 ± 
471 and –3,026 ± 489) at initial processing when 
compared to the other groups. When sorted by mor-
tality within group, calves that were treated twice and 
recovered (–847 ± 331) demonstrated a greater (P < 
0.05) protective capacity than calves that were treated 
twice and died (–2,264 ± 412), indicating that calves 
that contract BRDC and ultimately die might have 
reduced protective capacity against histone cytotox-
icity. Results suggest that calves that require multiple 
treatments for BRDC have reduced ability to protect 
against cytotoxicity of histones. Understanding the 
primary mechanism responsible for protecting against 
histone cytotoxicity could lead to improved identifica-
tion of animals susceptible to severe cases of BRDC, 
improved focus and use of available resources, or bet-
ter treatments for severe cases of BRDC.
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2001). Typically, BRDC involves a combination of a 
viral and bacterial coinfection. Adding to the complex-
ity, not all animals exposed to these pathogens exhibit 
clinical signs. The disease process can develop sepsis; 
however, physiological traits for increased suscepti-
bility or increased severity of BRDC remain unclear.
Recently, in humans and mice, extracellular his-
tones have been shown to be involved in death associ-
ated with a variety of pathologies including acute sepsis 
and injury (Xu et al., 2009, 2011). Moreover, histones 
are lethal when injected into mice (Xu et al., 2011), 
and serum appears to protect against histone cytotoxic-
ity (Wang et al., 1999). Several serum proteins have 
demonstrated the ability to bind to histones, and work 
by Abrams et al. (2013) demonstrated that C-reactive 
protein (CRP) binds to and neutralizes histone toxic-
ity. Therefore, we hypothesize that histone cytotoxicity 
contributes to the severity of BRDC and that cattle ex-
hibit varying degrees of protective capacity against the 
cytotoxic effects of histones. The objectives of the cur-
rent study were to establish an in vitro assay to test pro-
tective capacity of serum collected from feedlot cattle 
against cytotoxic effects of histones and to determine 
if protective capacity in cattle varies in relation to the 
degree of severity of naturally acquired BRDC.
MATERIALS AND METHODS
All procedures for the present experiment were ap-
proved by the Oklahoma State University Institutional 
Animal Care and Use Committee (Animal Care and 
Use Protocol AG-12-11).
Animals
Over a 1-wk period, 355 bulls (BW at arrival = 
217 ± 20 kg) were purchased from multiple live-
stock auctions throughout Oklahoma and transported 
(average distance = 135 km) to the Willard Sparks 
Beef Research Center at Oklahoma State University 
(Stillwater, OK). Upon arrival, calves were visually 
inspected for abnormalities or illness and subsequent-
ly uniquely identified and placed in pens with ad li-
bitum access to hay and water. Calves were allowed 
to rest 24 to 48 h before initial processing. Initial 
processing included vaccination against infectious 
bovine rhinotracheitis virus, bovine viral diarrhea vi-
rus types 1 and 2, parainfluenza 3 virus, and bovine 
respiratory syncytial virus (BRD Shield; Novartis, 
Greensboro, NC); Clostridium chauvoei, Clostridium 
septicum, Clostridium novyi, Clostridium sordellii, 
and Clostridium perfringens Types C and D (Caliber 
7; Boehringer-Ingelheim, St. Joseph, MO); and treat-
ment for the control of internal and external parasites 
(Ivomec Plus; Merial, Duluth, GA). Animals were 
surgically castrated by incising the scrotum with a 
Newberry castrating knife and then emasculation of 
the cord. Animals were monitored daily for clinical 
symptoms of BRDC.
The evaluation used criteria based on the de-
pression, appetite, respiration and temperature 
(DART) system (Pharmacia Upjohn Animal Health, 
Kalamazoo, MI) with some modifications as described 
by Step et al. (2008). The subjective criteria used for 
pulling calves consisted of depression, abnormal ap-
petite, and respiratory signs. The evaluators assigned 
a calf a severity score from 0 to 4 based on the clini-
cal signs and the severity of those signs. A score of 
0 was assigned for a clinically normal appearing calf. 
A score of 1 was assigned for mild clinical signs, 2 
for moderate clinical signs, 3 for severe clinical signs, 
and 4 for a moribund animal. The objective criteria 
used to determine if antimicrobial treatment was nec-
essary was rectal temperature. All calves assigned a 
severity score of 1 to 4 were taken to the processing 
chute for rectal temperature measurement (GL M-500 
thermometer; GLA Agricultural Electronics, San Luis 
Obispo, CA). Any animal that was pulled with a se-
verity score of 1 or 2 and had a rectal temperature of 
40°C or greater received an antimicrobial treatment 
according to label instructions. Any animal with se-
vere clinical signs (severity score = 3 or 4) received 
an antimicrobial according to label instructions re-
gardless of rectal temperature. For the first antimicro-
bial treatment, gamithromycin 150 mg/mL (Zactran; 
Merial) was administered at 1 mL/24.9 kg of BW. 
After 240 h for calves with a severity score of 1 or 
2 and 96 h for calves with a severity score of 3 or 4, 
florfenicol 300 mg/mL (Nuflor; Intervet/Schering-
Plough, Desoto, KS) was administered at the rate of 
1 mL/7.56 kg of BW. After 96 h after the florfenicol 
treatment, calves displaying severity scores of 1 or 
greater were administered ceftiofur crystalline free 
acid 200 mg/mL (Excede; Pfizer, New York, NY) at 
1 mL/30.2 kg of BW. A 168 h moratorium was ob-
served before administering a fourth antimicrobial 
treatment (ceftiofur; same dose as described above) as 
necessary. Postmortem necropsy was also performed 
on 3 random calves that died on different days within 
2 wk after arrival. This included nasal passage swabs 
and lung tissue sampling. Samples were evaluated 
by Oklahoma Animal Disease Diagnostic Lab Center 
for Veterinary Health Sciences at Oklahoma State 
University (Stillwater, OK).
A subset of 66 bulls was retrospectively assigned 
to groups consisting of control (CONT; n = 10), 
calves treated with antimicrobials once for BRDC 
(1T; n = 16), calves treated twice for BRDC (2T; n 
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= 13), calves treated 3 times for BRDC (3T; n = 14), 
and calves treated 4 times for BRDC (4T; n = 13). For 
within-group analysis, each group was separated into 
calves that recovered (R) and calves that died (D), re-
sulting in 8 different groups (calves that were treated 
once and recovered [1TR; n = 9] or died [1TD; n = 
7], calves that were treated twice and recovered [2TR; 
n = 6] or died [2TD; n = 7], calves that were treated 3 
times and recovered [3TR; n = 6] or recovered [3TD; 
n = 8], and calves that were treated 4 times and recov-
ered [4TR; n = 8] or died [4TD; n = 5]).
Serum Collection
Serum was collected at initial processing and each 
time a calf met the criteria for the standard feedlot defini-
tion for treatment of BRDC. A blood sample (9 mL) was 
collected via jugular venipuncture for subsequent serum 
analysis (Corvac Serum Separator Tube; Tyco Healthcare 
Group LP, Mansfield MA). Blood samples were allowed 
to clot at 4°C overnight and then centrifuged at 1,200 × 
g for 15 min at 4°C. The separated serum was placed in 
new tubes and frozen at –80°C until analysis.
Cell Culture
Immortal bovine kidney epithelial cells (Madin-
Darby bovine kidney [MDBK]) cells were cultured in 
phenol-free media (Dulbecco’s Modified Eagle Medium 
Nutrient Mixture F-12 [DMEM/F12; Life Technologies, 
Carlsbad, CA] supplemented with 5% fetal bovine se-
rum [Invitrogen, Carlsbad, CA] and 1% (vol/vol) 100 IU/
mL penicillin and 100 μg/mL streptomycin [Invitrogen]). 
Cells were incubated at 38.5°C for a minimum of 24 h. 
Cells were plated into 96-well culture plates at a conflu-
ency of 20% and allowed to attach overnight in complete 
media. After cells attached, media and unattached cells 
were removed and cells were incubated in serum-free 
media (DMEM/F12 + antibiotics) in the presence of his-
tones or water control (autoclaved, double deionized wa-
ter, pH 7.1) and the serum sample.
Histone and Serum Dose Response
To determine the lowest dose of total histones 
necessary to elicit cytotoxic activity, a histone dose-
response was conducted. Initial doses were selected 
based on previous work demonstrating histone cy-
totoxicity and serum histone levels in disease (Xu et 
al., 2009; Abrams et al., 2013). The MDBK cells were 
treated with a concentration of 0 (control), 25, 50, 100, 
and 200 μg/mL of total calf thymus histones (Santa 
Cruz Biotechnology, Dallas, TX) in serum-free media. 
Cytotoxicity was determined via visual appraisal and 
resazurin assay as an indicator of cell health (alamar-
Blue; Life Technologies). The 50 μg/mL of histones 
resulted in substantial cell death and was selected for 
subsequent studies (see results). The MDBK cells were 
then treated with 50 μg/mL of calf thymus histones 
and serum-free media supplemented with serum from 
calves not displaying symptoms of BRDC. Serum con-
centrations of 0, 1, 3, and 5% were tested with serum 
from 2 separate control animals (cattle with known 
background that never displayed clinical symptoms of 
injury or illness and exhibited protective capacity in 
preliminary experiments). Cell viability was estimated 
using alamarBlue (Life Technologies) according to 
manufacturer’s recommendations and fluorescence 
was detected using a Molecular Devices M3 (Molecular 
Devices, Sunnyvale, CA) plate reader. Cells were incu-
bated with treatment for 18 h and exposed to resazurin 
for 6 h before reading. Finally, a serum concentration 
× histone dose response was evaluated using 0.5 and 
1% serum and 50 and 100 μg/mL total histones. A se-
rum concentration of 1% and histone concentration of 
50 μg/mL was used for subsequent testing. This level 
of histones was chosen because higher concentrations 
could have cytotoxic effects despite serum. Likewise, 
1% serum was used because the lowest concentration 
that conferred protection would also be more suscep-
tible to histone cytotoxicity if animal variation in pro-
tective capacity existed.
Serum Protective Capacity Assay
Immortal bovine kidney epithelial cells were cul-
tured as described above. Following overnight attach-
ment, cells were incubated with serum-free media + 
1% serum from individual calves + vehicle (control) 
in duplicate wells of a 96-well plate to test for serum 
effects; duplicate wells were also incubated with phe-
nol serum-free media + 1% serum from individual 
calves + 50 μg/mL calf thymus histones. Cells were 
incubated with treatment for 18 h and exposed to re-
sazurin for 6 h before reading. Subsequently, fluores-
cent values for duplicates were averaged and serum + 
vehicle was subtracted from serum + histones for each 
animal. To evaluate potential toxicity of serum alone, 
each animal’s vehicle sample was also compared with 
fluorescent values from nontreated cells.
Statistics
Fluorescent values from serum samples collected at 
initial processing and incubated without histones were 
analyzed using the GLM procedure of SAS (SAS Inst. 
Inc., Cary, NC) for CONT, 1T, 2T, 3T, and 4T and fluo-
rescent means were estimated with the PDIFF function.
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Each animal’s normalized fluorescent value es-
timating histone cytotoxicity (fluorescent value for 
serum with histones – serum without histones; delta 
fluorescence) for serum samples collected at initial pro-
cessing was analyzed using the GLM procedure of SAS 
for CONT, 1T, 2T, 3T, and 4T. Means were estimated 
using the PDIFF function and data are presented as least 
squares means ± most conservative within-group SE.
To analyze histone protective capacity over time 
in the feedlot, animals that recovered were compared 
to animals that died within treatment group (1TR vs. 
1TD, 2TR vs. 2TD, 3TR vs. 3TD, and 4TR vs. 4TD). 
Serum samples were collected each time an animal 
received antibiotic therapy for BRDC and mortality 
versus recovery was considered treatment. The delta 
fluorescence was tested against treatment, time, and 
treatment × time for each group using the MIXED 
procedure of SAS. Three covariance structures were 
tested for optimal fit statistics and compound sym-
metry was chosen. Data are presented as least squares 
means ± most conservative within-group SE. For all 
experiments, significance was set at P < 0.10.
RESULTS
A marginal decline in MDBK cell viability was 
demonstrated in cells exposed to 25 μg/mL histones. 
Increased doses of histones (50 or 100 μg/mL) resulted 
in a substantial decline in cell viability but there was 
no difference between 50 or 100 μg/mL (Fig. 1). This 
devastating response to histones was visually evident 
as well. Microscopically, 50 μg/mL histones caused 
significant cell death (Fig. 2). As the lowest dose in-
ducing substantial cell death, 50 μg/mL of histones 
was used for subsequent serum optimization.
Concentrations of 0, 1, 3, and 5% serum from 2 
healthy calves were used in 2 separate assays to evalu-
ate serum protective capacity against 50 μg/mL his-
tones. Data are presented as percent of controls (cells 
without histones and serum). Without serum, 50 μg/
mL histones caused a reduction in cell viability, but 
addition of the nominal 1% serum restored viabil-
ity to levels near the histone-free control (Fig. 1). To 
further refine the serum protective capacity assay, a 
serum by dose-response experiment was conducted. 
Healthy calf serum concentrations of 0, 0.5, and 1% 
were tested against 0, 25, 50, and 100 μg/mL of his-
tones (Fig. 1). The 0% serum concentration showed a 
response similar to previous optimization steps where 
50 and 100 μg/mL histones were extremely toxic to 
cells. However, no difference was observed between 
50 and 100 μg/mL histones. Although 0.5% serum 
did decrease histone cytotoxicity relative to nonse-
rum samples, this percent was not able to fully pro-
tect against histone cytotoxicity. However, 1% serum 
restored fluorescent values in 50 and 100 μg/mL of 
histones to near control (histone-free serum) levels. 
Because 1% serum was the lowest concentration of se-
rum that conferred resistance and 50 μg/mL histones 
was the lowest dose required to induce cytotoxicity, 
these were chosen to test the protective capacity of se-
rum in experimental animals.
Serum samples from CONT, 1T, 2T, 3T, and 4T 
collected at initial processing were evaluated using the 
resazurin assay. Fluorescent values were obtained in 
the absence of histone treatment and in the presence 
of 1% serum for each animal to evaluate toxicity ef-
fects of the serum alone and to provide a baseline value 
for each individual animal. In the absence of histones, 
there was no difference (P > 0.20) in fluorescent values 
between any of the groups, indicating that there were 
no toxicity effects of serum alone (Fig. 3A); addition-
ally, there was no difference between serum-treated 
samples and nontreated cells (data not shown). Cells 
incubated with 50 μg/mL of histones did not differ in 
CONT, 1T, and 2T (P > 0.20). However, calves that 
required 3 or more treatments for BRDC exhibited a 
decreased (P < 0.05) capacity to protect against histone 
cytotoxicity compared with CONT (Fig. 3B) at initial 
processing. Relative to their own serum sample tested 
without histones, serum from 3T and 4T had fluorescent 
values of –2,778 ± 471 and –3,025 ± 489, respectively, 
Figure 1. Bovine kidney epithelial cells treated with varying concen-
trations (0, 25, 50, and 100 μg/mL) of total histones from calf thymus in 
media containing no serum or serum from control calves (never displayed 
clinical symptoms of illness; n = 2). Control serum was administered at 0, 
0.5, and 1% with each histone concentration. Resazurin assay was used 
as an estimate of cell viability and fluorescent values were obtained 24 h 
after treatment with histones and serum. The change in fluorescence was 
calculated with the average of 0 μg/mL of histones as the baseline for each 
serum concentration. This baseline was subtracted from the corresponding 
serum concentration at greater histone concentrations to give the change in 
cell viability due to histone effect. The objective of the experiment was to 
determine the lowest concentration of serum and lowest dose of histones 
required to exhibit fluorescent values comparable to control. As in previ-
ous experiments (data not shown), results demonstrated that 50 μg/mL of 
histones was required to induce substantial cell death and 1% serum was 
required to fully protect against 50 μg/mL total histones. 
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when incubated with 50 μg/mL histones. Serum sam-
ples from CONT were able to protect against histone 
toxicity and had fluorescent values near their own non-
histone baseline (–312 ± 557; Fig. 3B). Calves treated 
with antimicrobials once for BRDC and 2T displayed 
protective capacities similar to (P > 0.10) CONT and 
were approximately –1,000 for both groups.
Serum samples were also collected each time an 
animal received antimicrobial treatment for BRDC, 
and those that required treatment for BRDC were sort-
ed within group (i.e., 1T, 2T, 3T, or 4T) by calves that 
recovered and calves that died. To determine if pro-
tective capacity against histone cytotoxicity changed 
between calves that lived and those that died, serum 
samples within group were analyzed against time, 
treatment (recovered or died), and treatment × time 
interactions. For 1T, 3T, or 4T, there was no effect of 
mortality or time on the protective capacity against 
histones (P > 0.10; Fig. 4A, 4C, and 4D). However, 
there was a treatment effect for the 2T group. Calves 
that were treated twice for BRDC and recovered had a 
greater (P < 0.05) overall protective capacity than 2T 
that ended up dying (Fig. 4B).
DISCUSSION
Bovine respiratory disease complex remains the 
main cause of morbidity and mortality in feedlot cattle. 
Despite much research effort, BRDC cases have been 
relatively constant over the past 30 yr (reviewed by 
Gifford et al., 2012) and contribute to decreased eco-
nomic returns due to treatment costs, decreased carcass 
quality, depressed growth, and death loss. Bovine re-
spiratory disease complex is a multifaceted disease and 
the etiological agents are typically viral and bacterial or 
mycoplasmal. The most common viral agents observed 
are bovine herpesvirus 1, bovine parainfluenza virus 3, 
bovine viral diarrhea virus 1 and 2, bovine coronavi-
rus, and bovine adenovirus; typical bacterial agents are 
Mannheimia haemolytica, Pasteurella multocida, and 
Histophilus somni (reviewed by Griffin et al., 2010). 
Mycoplasma species can also be pathogens in BRDC 
outbreaks (reviewed by Griffin et al., 2010). Although 
pathogens can vary in cases of BRDC, a hallmark of the 
disease is respiratory tract infections resulting in pneu-
monia and bronchiolar lesions (Fulton et al., 2009). In the 
current study, postmortem necropsy of 3 calves identified 
Figure 2. Bovine kidney epithelial cells were treated with 1% serum of representative protective (against histone cytotoxicity) and nonprotective 
calves and with or without 50 μg/mL total histones. Calves were classified as protective or nonprotective based on previous experiments. Pictures of cells 
in culture were taken after 24 h treatment with histones, serum, or both. Column A: Cells treated with 1% serum and no histones from a representative 
protective animal (top) and a representative nonprotective animal (bottom). Column B: Cells treated with 50 μg/mL of histones and 1% serum from a rep-
resentative protective animal (top) and a representative nonprotective animal (bottom). Column C: Cells treated with 50 μg/mL of histones and no serum.
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several pathogens including Mannheimia haemolytica, 
Mycoplasma bovis, bovine viral diarrhea virus, Bovine 
coronavirus, and Pasteurella multocida and calves ex-
hibited greater than 85% lung damage. Additionally, 
the severity of the disease varied both in length (calves 
requiring only 1 antimicrobial treatment up to 4 treat-
ments) of clinical signs and varied times to death (calves 
that died after 1 treatment, 2 treatments, 3 treatments, or 
4 treatments). The varied severity of disease likely stems 
from variation of individual resistance (Snowder et al., 
2006) and the multiple pathogens involved (Fulton et al., 
2009; Kirchhoff et al., 2014). However, for all groups in 
the current study, the average time to first treatment was 
6 ± 1.5 d, indicating that all animals suffered similar ex-
posure on arrival. Ultimately, the resulting experimental 
group had calves that exhibited varied severity of BRDC 
ranging from acute to chronic.
Pathologies that induce necrosis (either acute or 
chronic) or, in some cases, apoptosis cause release of 
histones into the extracellular spaces (Xu et al., 2009). 
Histone proteins (H1, H2A, H2B, H3, H4, and H5) 
help maintain the highly organized structure of DNA 
in chromatin format within the nucleus of eukaryotic 
cells. A nucleosome consists of 1 H3/H4 tetramer and 
2 H2A/H2B dimers; this histone octomer coils 147 bp 
of DNA. Together with the linker histones, H1 and H5, 
nucleosomes form higher order chromatin structures 
(Felsenfeld and Groudine, 2003). In human patients 
with acute respiratory distress syndrome and in mice 
with experimentally induced acute lung injury, extra-
cellular histones are detected in bronchoalveolar la-
vage fluid (Ward and Grailer, 2014). Likewise, Wen et 
al. (2013) demonstrated increased circulating histones 
in a mouse model for acute liver failure and sourced 
the histones to apoptotic hepatocytes and infiltrating 
neutrophils. Additionally, there are numerous other dis-
eases and injuries that can cause a rise in circulating 
histone levels of humans, mice, and baboons (reviewed 
by Allam et al., 2014), but studies in cattle experienc-
ing BRDC are lacking. Typically, lung damage occurs 
during episodes of BRDC and other species that suffer 
acute respiratory damage from disease or injury exhibit 
a rise in extracellular histones; it is reasonable to specu-
late that histones are released during BRDC as well. In 
the current experiment, serum samples were harvested 
and stored according to normal laboratory procedures. 
However, nucleosomes in serum are degraded rela-
tively quickly and require stabilization with EDTA to 
reliably quantify nucleosomes/histones after freezing 
samples (Holdenrieder et al., 2001). Moreover, samples 
must be harvested and processed in a similar manner, 
preferably in under 2 h (Holdenrieder et al., 2001). The 
samples collected for these data were allowed to clot 
overnight at 4°C and were not stabilized with EDTA; 
therefore, it seemed unlikely that circulating histones 
could be accurately quantified in these samples. If there 
were increased serum histones in some samples at arriv-
al, it would seem likely those serum samples would be 
cytotoxic to MDBK cells. There were no detectable dif-
ferences in cytotoxicity of serum samples from any of 
the groups at initial processing, indicating that histones 
or other factors in the samples were not contributing to 
the observed cytotoxicity.
Figure 3. A. Serum samples were collected from 66 bulls at initial 
processing. Animals were retrospectively assigned to groups consisting 
of calves that never received antibiotic treatment for bovine respiratory 
disease complex (BRDC; CONT; n = 10), calves treated with antimicro-
bials once for BRDC (1T; n = 16), treated twice for BRDC (2T; n = 13), 
calves treated 3 times for BRDC (3T; n = 14), or calves treated 4 times for 
BRDC (4T; n = 13). A) For each animal, 1% serum was incubated alone 
on bovine kidney epithelial cells (MDBK cells). Resazurin assay was used 
as an estimate of cell viability and fluorescent values were obtained 24 
h after treatment with serum. Data for the 1% serum alone baseline was 
evaluated using GLM procedure with no significance (P > 0.20) between 
groups. Results show that serum alone collected at initial processing is not 
cytotoxic. B) For each animal, 1% serum was incubated alone and in com-
bination with 50 μg/mL of histones on MDBK cells. Resazurin assay was 
used as an estimate of cell viability and fluorescent values were obtained 
24 h after treatment with histones. Data from each animal’s fluorescent 
value obtained from serum without histones served as a baseline for that 
animal. Baseline values were subtracted from respective fluorescent values 
obtained from incubating MDBK cells with serum + histones. Data are 
presented as least squares means ± most conservative within-group SE. 
Columns with different letters indicates significance (P < 0.05). Results 
show that calves that require multiple treatments for BRDC exhibit a de-
creased capacity to protect against histone cytotoxicity. 
Histones in bovine respiratory disease 1847
The physiological significance of extracellular 
histones in disease was first demonstrated by Xu et al. 
(2009), in which an inflammatory challenge led to a rise 
in extracellular histones and resulted in organ failure 
and ultimately death during sepsis. Exogenous histones 
administered intravenously to mice also elicit a hy-
perinflammatory response leading to cell damage and 
animal death (Xu et al., 2009). Intratracheal administra-
tion of histones greatly induces inflammation leading 
to epithelial damage, lung consolidation, and death in 
some cases (Ward and Grailer, 2014). In the absence of 
serum, we also observed complete cell death in MDBK 
cells treated with histones. However, histones not only 
directly induce cell death but can also hyperstimulate 
the proinflammatory response during a variety of con-
ditions including acute liver failure (Wen et al., 2013). 
During systemic inflammatory responses from disease 
or injury, it appears that histones bind toll-like receptors 
(TLR). Using a subfatal dose of histones administered 
to mice, Xu et al. (2011) found evidence of TLR2 and 
TLR4 signaling. Furthermore, when injected with ex-
ogenous histones, TLR4 knockout mice did not show 
massive proinflammatory cytokine production. This 
evidence, in addition to an in vitro model showing di-
rect activation of TLR by exogenous histone treatment, 
strongly implicates the importance of TLR in histone-
induced cytokine production and direct cell or organ 
damage (Xu et al., 2011).
Increasing evidence supports that there are physi-
ological adaptations to protect against histone toxicity. 
Aside from identifying extracellular histones as cyto-
toxic, Xu et al. (2009) noted that activated protein-c 
Figure 4. Serum samples were collected from 66 bulls at initial processing (IP) and at each treatment with antimicrobials for bovine respiratory disease 
complex (BRDC). Calves (n = 10) that never received treatment for BRDC are not included in figure. Animals were retrospectively assigned to groups consist-
ing of calves treated once for BRDC (n = 16), treated twice for BRDC (n = 13), calves that received 3 treatments for BRDC (n = 14), or calves that received 4 
treatments for BRDC (n = 13). Within each group, calves were further assigned as dead after last treatment (D; dashed lines) or recovered after last treatment 
(R; solid lines). Calves receiving the same total number of treatments were compared across their respective treatments. Samples collected at each treatment 
are designated as 1T (calves treated with antimicrobials once for BRDC), 2T (calves treated twice for BRDC), 3T (calves treated 3 times for BRDC), and 4T 
(calves treated 4 times for BRDC). For each animal, 1% serum was incubated alone and in combination with 50 μg/mL of histones on bovine kidney epithelial 
cells (MDBK cells). Resazurin assay was used as an estimate of cell viability and fluorescent values were obtained 24 h after treatment with histones. Each 
animal’s fluorescent value was calculated with serum without histones serving as a baseline for that animal. Baseline values were subtracted from fluorescent 
values obtained from incubating MDBK cells with serum + histones. A) Calves that were treated once and died (1TD; n = 7) or recovered (1TR; n = 9). There 
was no effect of mortality (P > 0.10) on serum protective capacity between calves that recovered and those that died. B) Calves that were treated twice and 
died (2TD; n = 7) or recovered (2TR; n = 6). There was an overall effect of mortality on histone protective capacity (P < 0.05). Overall, 2TD had a decreased 
capacity to protect against histone toxicity compared with 2TR. C) Calves that were treated 3 times and died (3TD; n = 8) or recovered (3TR; n = 6). Overall 
histone protective capacity was similar for those that died versus those that recovered. D) Calves that were treated 4 times and died (4TD; n = 5) or recovered 
(4TR; n = 8). Although initially similar, after 1 treatment 4TD began to show a numerical decline in protective capacity whereas 4TR had a numerical increase 
in protection against histones after 3 treatments. Nonetheless, there was no overall difference (P > 0.20) between calves that died and those that recovered. 
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infusion in combination with histones protected mice 
from the lethal effects of exogenous histones. Treatment 
with CRP also protected mice from lethal doses of ex-
ogenous histones (Abrams et al., 2013). Pemberton et 
al. (2010) found numerous serum proteins, including 
the acute phase protein fibrinogen, that bound histones, 
but the protective capacity of these proteins is unde-
termined. Results in the present study indicate that in-
creasing the concentration of serum greatly decreased 
histone toxicity. Collectively, these studies indicate that 
serum can protect against histone toxicity and that indi-
viduals may exhibit varied levels of protection.
In cattle, there is a varied response to the BRDC 
pathogens among individual animals. Although ex-
posure level and specific pathogen can contribute to 
varied levels of disease, individual susceptibility may 
also be important (Snowder et al., 2006). In the current 
study, calves were physically castrated on arrival; thus, 
these animals experienced both tissue injury and acute 
clinical infection. Although not directly measured, it 
would seem these calves would likely exhibit increased 
levels of circulating histones. Because histones can 
exacerbate inflammation, it is interesting to speculate 
that castration might lead to an increase in extracellular 
histones. In turn, the extracellular histones might alter 
the cytokine profile and, along with the stress response, 
make bulls more susceptible to BRDC.
Nonetheless, we reasoned that, similar to other spe-
cies, calves would demonstrate varying protective ca-
pacity against histone toxicity and those that were least 
protective would suffer more severe cases of BRDC as 
indicated by death or duration of illness. Results indi-
cated that serum samples from calves collected at initial 
processing had varied protective capacities against his-
tone cytotoxicity, and calves that ultimately required 3 
or more treatments for BRDC were the least protective. 
Interestingly, the decreased capacity was observed from 
serum samples collected at initial processing and before 
clinical symptoms of BRDC. Certainly, larger studies 
are necessary, but these data could suggest that histone 
toxicity protective capacity might be of use to predict 
which calves will exhibit longer durations of clini-
cal disease and require multiple treatments. Because 
chronically infected calves experience the most detri-
ment to carcass traits (Holland et al., 2010), perhaps 
these animals could be managed differently if identified 
early to minimize economic losses. Ideally, the mecha-
nism or mechanisms for histone protective capacity will 
be found, leading to new treatments or genetic screen-
ing of susceptible individuals.
At initial processing, there was no difference in pro-
tective capacity between calves that recovered and those 
that died within a group. When groups (1T, 2T, 3T, and 
4T) were separated by those that recovered and those that 
died, there were no treatment, time, or treatment × time 
interactions for histone protective capacity in the 1T, 3T, 
and 4T groups. There was a treatment effect for the 2T 
group, and animals that recovered displayed greater pro-
tection against the cytotoxic effects of histones than those 
that died, but studies with a larger sample size would be 
necessary to confirm these findings.
We initially predicted that calves that die from 
BRDC would have decreased capacity to protect against 
histone toxicity. Although not significant, a trend could 
be emerging from the current data in which animals 
that recover from BRDC display increasing protec-
tive capacity whereas those that die show decreased 
protective capacity over time. Results from the current 
study do not statistically support differences in protec-
tive capacity based on mortality, but the concept should 
be revisited with larger sample sizes or assays that 
directly measure the protective mechanism or mecha-
nisms against histone cytotoxicity. Additionally, serum 
histone levels could be quantified in properly handled 
serum samples. Certainly, other components of BRDC 
are likely contributors to death and histone cytotoxicity 
is not the sole contributor to clinical BRDC symptoms. 
It is also possible that calves that die have a massive 
rise in extracellular histones overriding any protective 
capacity; therefore, histone levels as well as protective 
capacity can be contributors to death in BRDC. Larger 
studies with appropriately processed serum are neces-
sary to describe histone release during BRDC.
In conclusion, as in other species, cattle serum is 
able to protect against extracellular histone toxicity. 
Additionally, individual animals exhibit a varied capac-
ity to protect against histone cytotoxicity, and calves 
that require multiple treatments for BRDC show an 
impaired capacity to protect against toxic effects of ex-
tracellular histones. Future work is needed to identify 
components of the serum that confer protection and to 
quantify extracellular histone levels during BRDC.
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